Daniel Shevrin to Mifepristone
This is a "connection" page, showing publications Daniel Shevrin has written about Mifepristone.
Connection Strength
0.053
-
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1549-1559.
Score: 0.053